Michael Linde

Michael oversees scientific strategy and tactics for the viral, liver, and rare disease therapeutic areas. With 20 years’ experience, Michael has worked on a diverse set of topics and deliverables, working with medical communications agencies, academics, advocacy and patient groups, promotions, advertising, and continuing medical education. He has expertise in commercial, medical, and market access strategy and content.

After majoring in biology and English at Emory University, Michael split the difference and went into medical writing. He began his medical communications career in 1998 as the primary writer for the Centers for Disease Control and Prevention’s National Prevention Information Network’s daily electronic “HIV/TB/STD News Update.” Michael later worked as a medical writer specializing in HIV for the medical communications company MediSolutions. He also spent many years as a freelance medical writer, working on a broad set of topics, including virology, allergy and immunology, autoimmune disease, diabetes, and healthcare reform and delivery, among many others.

Michael also spent many years as an academic researcher. He received his PhD in immunology from the Johns Hopkins School of Medicine, where he studied HIV entry, trafficking, and budding, and a Master of Science degree from the University of Southern California for his work on RNA-binding protein kinetics. He has been published in the Journal of Proteome Research, Journal of Neuroimmune Pharmacology, Journal of Virology, and Nucleic Acids Research.